Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients
Preedom
1 other identifier
observational
2,000
1 country
4
Brief Summary
The purpose of this study is to asses the EED symptom prevalence in Koran GERD patients with typical reflux symptom and to evaluate quality of life with the scales including Gerd Q.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2008
Shorter than P25 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2008
CompletedFirst Submitted
Initial submission to the registry
October 1, 2008
CompletedFirst Posted
Study publicly available on registry
October 7, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2009
CompletedDecember 7, 2010
December 1, 2010
October 1, 2008
December 6, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary variable is the total rate of GERD patients who had EED symptom and effect on their quality of life.
Secondary Outcomes (1)
The secondary variable is the comparison of the EED symptom frequency in ERD and NERD patients.
Eligibility Criteria
general hospital sample
You may qualify if:
- GERD patients who have experienced heartburn or acid regurgitation during past 7 days
- GERD patients who have already undergone endoscopy before enrolment
You may not qualify if:
- Involvement in the planning and conduct of the programme
- The person who took the medicine such as PPI or H2RA during the last 7 days
- Severe systemic disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (4)
Research Site
Cheonan, Chungcheongnam-do, South Korea
Research Site
Seoul, Kyungkido, South Korea
Research Site
Sungnam, Kyungkido, South Korea
Research Site
Suwon, Kyungkido, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Joon-Woo Bahn
AstraZeneca Korea
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
October 1, 2008
First Posted
October 7, 2008
Study Start
September 1, 2008
Study Completion
February 1, 2009
Last Updated
December 7, 2010
Record last verified: 2010-12